Analysis of Characteristics Among Users of Tami, a Digital Companion for Managing Inflammatory Bowel Disease

• by Ann-Sophie Stratil, Benjamin Friedrich, Tim Hahn, Andreas Lügering, Steffeni Papukchieva

• February 1, 2026

UCI Health hosts IBD transition of care open house

UCI Health hosted a World IBD Day open house designed to support young adults with inflammatory bowel disease.

• by

• June 19, 2026

• 1 min

This Week’s Biopharma News: Amgen Deepens US Manufacturing Push

The company adds $300 million to its Puerto Rico biologics site as Pfizer reports Phase 3 myeloma data, J&J advances a dual-pathway IBD antibody, and BioNTech streamlines production

• May 12, 2026

• 7 min

Anti-TNF immunogenicity in a Middle Eastern inflammatory bowel disease cohort: prevalence, predictors and context-specific drug level thresholds

• by Shaima Wasim Khan, Noorah Al Hosani, Thaer Khaleel Swaid, Mazin M Edan, Mohammed Nabil Quraishi

• June 26, 2026